Da traduttori professionisti, imprese, pagine web e archivi di traduzione disponibili gratuitamente al pubblico.
gm- csf receptor antagonist
gm-csf receptor antagonist
Ultimo aggiornamento 2011-10-23
Frequenza di utilizzo: 2
Qualità:
Attenzione: Questo allineamento potrebbe essere errato.
Eliminalo se ritieni che sia così.
myristolated- peptidyl - recombinant scr1- 3 of human complement receptor type i
myristolated-peptidyl- recombinant scr1-3 of human complement
Ultimo aggiornamento 2011-10-23
Frequenza di utilizzo: 1
Qualità:
Attenzione: Questo allineamento potrebbe essere errato.
Eliminalo se ritieni che sia così.
Η ροσιγλιταζόνη είναι ένας εκλεκτικός αγωνιστής των πυρηνικών υποδοχέων ppar (peroxisome proliferator activated receptor gamma) και ανήκει στην κατηγορία των θειαζολιδινεδιονικών αντιυπεργλυκαιμικών παραγόντων.
rosiglitazone is a selective agonist at the ppar (peroxisome proliferator activated receptor gamma) nuclear receptor and is a member of the thiazolidinedione class of antihyperglycaemic agents.
Ultimo aggiornamento 2017-04-26
Frequenza di utilizzo: 1
Qualità:
Ροσιγλιταζόνη Η ροσιγλιταζόνη είναι εκλεκτικός αγωνιστής του pparγ (peroxisome proliferator activated receptor gamma) πυρηνικού υποδοχέα και είναι μέλος της κατηγορίας των θειαζολιδινεδιονικών αντιυπεργλυκαιμικών παραγόντων.
rosiglitazone rosiglitazone is a selective agonist at the ppar (peroxisome proliferator activated receptor gamma) nuclear receptor and is a member of the thiazolidinedione class of antihyperglycaemic agents.
Ultimo aggiornamento 2008-03-04
Frequenza di utilizzo: 4
Qualità:
Attenzione: Questo allineamento potrebbe essere errato.
Eliminalo se ritieni che sia così.
Η τραστουζουμάμπη είναι ένα ανασυνδυασμένο εξανθρωποποιημένο igg1 μονοκλωνικό αντίσωμα έναντι του υποδοχέα 2 του ανθρώπινου επιδερμικού αυξητικού παράγοντα (human epidermal growth factor receptor 2 - her2).
trastuzumab is a recombinant humanised igg1 monoclonal antibody against the human epidermal growth factor receptor 2 (her2).
Ultimo aggiornamento 2017-04-26
Frequenza di utilizzo: 3
Qualità:
Αυξήσεις των ηπατικών ενζύμων, δυνητικώς σχετιζόμενες με τη θεραπεία, έχουν παρατηρηθεί με ανταγωνιστές των υποδοχέων ενδοθηλίνης (endothelin receptor antagonists- eras) (βλέπε παράγραφο 5. 1).
hepatic enzyme elevations potentially related to therapy have been observed with endothelin receptor antagonists (eras) (see section 5.1).
Ultimo aggiornamento 2012-04-11
Frequenza di utilizzo: 4
Qualità: